Statistics & Data Corporation (SDC) is fully committed to providing Clients with top-tier service throughout the entire clinical trial process. We also understand that additional support will sometimes be necessary once a study is complete to help guide a Client’s product toward approval. Post-hoc analysis can be critical to the success of any clinical phase program.
SDC was asked to complete a multicenter Phase 2 adaptive study which included an interim analysis. This study included enrollment of over 200 subjects with 100+ eCRFs collected throughout the study. Upon completion, post-hoc analysis was needed to support moving forward into Phase 3 studies.
Download this Case Study to Learn more.